Marilena Pontoriero

Dr. Marilena Pontoriero

Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Calabria, Italy
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2019 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
MPMarilena Pontoriero
Marilena Pontoriero
Giuseppe FiumeGiuseppe Fiume
Giuseppe Fiume
Eleonora VecchioEleonora Vecchio
Eleonora Vecchio
ALAnnamaria de Laurentiis
Annamaria de Laurentiis
Francesco AlbanoFrancesco Albano
Francesco Albano
IQIleana Quinto
Ileana Quinto

7 September 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Giuseppe FiumeGiuseppe Fiume
Giuseppe Fiume
ASAnnarita Scialdone
Annarita Scialdone
Francesco AlbanoFrancesco Albano
Francesco Albano
ARAnnalisa Rossi
Annalisa Rossi
FTFranca Maria Tuccillo
Franca Maria Tuccillo
IQIleana Quinto
Ileana Quinto
Immune activation and chronic inflammation are hallmark features of HIV infection causing T-cell depletion and cellular immune dysfunction in AIDS. Here, we addressed the issue whether HIV-1 Tat could affect T cell development and acute inflammatory response by generating a transgenic mouse expressing Tat in lymphoid tissue. Tat-Tg mice showed thymus atrophy and the maturation block from DN4 to DP thymic subpopulations, resulting in CD4+ and CD8+ T cells depletion in peripheral blood. In Tat-positive thymus, we observed the increased p65/NF-κB activity and deregulated expression of cytokines/chemokines and microRNA-181a-1, which are involved in T-lymphopoiesis. Upon LPS intraperitoneal injection, Tat-Tg mice developed an abnormal acute inflammatory response, which was characterized by enhanced lethality and production of inflammatory cytokines. Based on these findings, Tat-Tg mouse could represent an animal model for testing adjunctive therapies of HIV-1-associated inflammation and immune deregulation.

1 May 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
APAntonio Pisano
Antonio Pisano
SCSimona Ceglia
Simona Ceglia
Camillo PalmieriCamillo Palmieri
Camillo Palmieri
EVEleonora Vecchio
Eleonora Vecchio
Giuseppe FiumeGiuseppe Fiume
Giuseppe Fiume
IQIleana Quinto
Ileana Quinto
The human inhibitor of Bruton's tyrosine kinase isoform α (IBtkα) is a BTB protein encoded by the IBTK gene, which maps to chromosomal locus 6q14.1, a mutational hot spot in lymphoproliferative disorders. Here, we demonstrate that IBtkα forms a CRL3IBTK complex promoting its self-ubiquitylation. We identified the tumor suppressor Pdcd4 as IBtkα interactor and ubiquitylation substrate of CRL3IBTK for proteasomal degradation. Serum-induced degradation of Pdcd4 required both IBtkα and Cul3, indicating that CRL3IBTK regulated the Pdcd4 stability in serum signaling. By promoting Pdcd4 degradation, IBtkα counteracted the suppressive effect of Pdcd4 on translation of reporter luciferase mRNAs with stem-loop structured or unstructured 5′-UTR. IBtkα depletion by RNAi caused Pdcd4 accumulation and decreased the translation of Bcl-xL mRNA, a well known target of Pdcd4 repression. By characterizing CRL3IBTK as a novel ubiquitin ligase, this study provides new insights into regulatory mechanisms of cellular pathways, such as the Pdcd4-dependent translation of mRNAs.

29 August 2016 in Leukemia
Verified
Journal Article
Open access
SMSelena Mimmi
Selena Mimmi
Eleonora VecchioEleonora Vecchio
Eleonora Vecchio
EIE Iaccino
E Iaccino
MRMarco Rossi
Marco Rossi
Antonio LupiaAntonio Lupia
Antonio Lupia
Camillo PalmieriCamillo Palmieri
Camillo Palmieri
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.

11 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Giuseppe FiumeGiuseppe Fiume
Giuseppe Fiume
ARAnnalisa Rossi
Annalisa Rossi
ALAnnamaria de Laurentiis
Annamaria de Laurentiis
CFCristina Falcone
Cristina Falcone
APAntonio Pisano
Antonio Pisano
IQIleana Quinto
Ileana Quinto
Protein synthesis is mainly regulated at the initiation step, allowing the fast, reversible and spatial control of gene expression. Initiation of protein synthesis requires at least 13 translation initiation factors to assemble the 80S ribosomal initiation complex. Loss of translation control may result in cell malignant transformation. Here, we asked whether translational initiation factors could be regulated by NF-κB transcription factor, a major regulator of genes involved in cell proliferation, survival, and inflammatory response. We show that the p65 subunit of NF-κB activates the transcription of eIF4H gene, which is the regulatory subunit of eIF4A, the most relevant RNA helicase in translation initiation. The p65-dependent transcriptional activation of eIF4H increased the eIF4H protein content augmenting the rate of global protein synthesis. In this context, our results provide novel insights into protein synthesis regulation in response to NF-κB activation signalling, suggesting a transcription-translation coupled mechanism of control.

Verified
Journal Article
Open access
PDF file
Giuseppe FiumeGiuseppe Fiume
Giuseppe Fiume
ASAnnarita Scialdone
Annarita Scialdone
Francesca RizzoFrancesca Rizzo
Francesca Rizzo
MFMaria Rosaria De Filippo
Maria Rosaria De Filippo
CLCarmelo Laudanna
Carmelo Laudanna
IQIleana Quinto
Ileana Quinto
The IBTK gene encodes the major protein isoform IBTKα that was recently characterized as substrate receptor of Cul3-dependent E3 ligase, regulating ubiquitination coupled to proteasomal degradation of Pdcd4, an inhibitor of translation. Due to the presence of Ankyrin-BTB-RCC1 domains that mediate several protein-protein interactions, IBTKα could exert expanded regulatory roles, including interaction with transcription regulators. To verify the effects of IBTKα on gene expression, we analyzed HeLa and K562 cell transcriptomes by RNA-Sequencing before and after IBTK knock-down by shRNA transduction. In HeLa cells, 1285 (2.03%) of 63,128 mapped transcripts were differentially expressed in IBTK-shRNA-transduced cells, as compared to cells treated with control-shRNA, with 587 upregulated (45.7%) and 698 downregulated (54.3%) RNAs. In K562 cells, 1959 (3.1%) of 63128 mapped RNAs were differentially expressed in IBTK-shRNA-transduced cells, including 1053 upregulated (53.7%) and 906 downregulated (46.3%). Only 137 transcripts (0.22%) were commonly deregulated by IBTK silencing in both HeLa and K562 cells, indicating that most IBTKα effects on gene expression are cell type-specific. Based on gene ontology classification, the genes responsive to IBTK are involved in different biological processes, including in particular chromatin and nucleosomal organization, gene expression regulation, and cellular traffic and migration. In addition, IBTK RNA interference affected RNA maturation in both cell lines, as shown by the evidence of alternative 3′- and 5′-splicing, mutually exclusive exons, retained introns, and skipped exons. Altogether, these results indicate that IBTK differently modulates gene expression and RNA splicing in HeLa and K562 cells, demonstrating a novel biological role of this protein.